Home About Us Contact Us

 

Table of Content - Volume 20 Issue 1 - October 2021


 

Study of hemodynamic parameters and cardiac function in patients undergoing laparoscopic cholecystectomy in patients with moderate to severe left ventricular dysfunction

 

Varsha Sapehia1, Kamlesh2*, Prerna Verma3, Kajal Jain4, Tanvir Samra5, Komal Ghandhi6, lileshwar Kaman7

 

1Junior Resident, 3,6Assistant Professor, 4Professor, 5Associate Professor, Department of Anaesthesia & Intensive Care}

{7Professor, Department of General Surgery} PGIMER, Chandigarh, INDIA.

2Junior Resident, Department of Obstetrics & Gynaecology, Kamla Nehru Hospital, Shimla, Himachal Pradesh, INDIA.

Email: varshasapehia@gmail.com

 

Abstract              Background: Laparoscopic cholecystectomy has gained much popularity as being an effective surgical procedure to cholelithiasis as compared to open cholecystectomy. Whether the laparoscopic cholecystectomy be beneficial in patients having cardiac dysfunction as the advantage will be less physiological stress and disadvantage of pneumoperitoneum is a matter of concern for surgeon as well as anesthetist. In present study, hemodynamic parameters and cardiac function in patients undergoing laparoscopic cholecystectomy in patients with moderate to severe left ventricular dysfunction was studied. Material and Methods: Present study was prospective, comparative study, conducted in p patients 18-65 years age, with echocardiographic findings consistent with presence of moderate to severe left ventricular systolic dysfunction, planned for laparoscopic cholecystectomy, Results: 15 patients with moderate to severe LV dysfunction undergoing laparoscopic cholecystectomy were enrolled in the study. In present study, mean age was 55.57 ± 7.52 years. Gender wise male (26.67 %) were less than female (73.3 %) patients. Medical comorbidities were Hypertension (80 %), Diabetes mellites 3 (20 %) and Previous history of cardiac intervention (20 %). 73.3 % patients had moderate Left ventricular dysfunction (LVEF 36–40%) while 26.67 % had severe Left ventricular dysfunction (LVEF < 36%). The mean HR values, decrease in mean HR was 6.5% On intragroup statistical analysis, no significant change in mean HR is seen at T2, T3, T4 or T5 from T1 was noted. From T1 to T2, the fall in mean MAP was 9.7% while from T2 to T3, 32.5% increase in MAP was seen. On intragroup statistical analysis, no significant change in mean MAP was noted. 4 patients had episodes of hypotension, 1 patient in had an episode of bradycardia requiring intervention. No significant complications occurred during immediate postoperative period as well as during the hospital stay. Conclusion: Laparoscopic cholecystectomy may be safely done in cardiac patients with moderate to severe left ventricular systolic dysfunction patients under the supervision of an experienced consultant anaesthesiologist.

Keywords: laparoscopic cholecystectomy, left ventricular systolic dysfunction, balanced anaesthesia, pneumoperitoneum

 

INTRODUCTION

Laparoscopic cholecystectomy has gained much popularity as being an effective surgical procedure to cholelithiasis as compared to open cholecystectomy.1Laparoscopic cholecystectomy minimizes abdominal incision and therefore pulmonary function and diaphragmatic function remain preserved. Laparoscopic cholecystectomy decreases the incidence of postoperative ileus, helps early ambulation, has economic benefits, helps early ambulation with shorter hospital stay, early return to work and normal daily activities.2 Pneumoperitoneum created during laparoscopic surgeries have serious impacts on various systems including cardiovascular system. So in patients with cardiac abnormality laparoscopic cholecystectomy should be better avoided.3 But, patients undergoing laparoscopic cholecystectomy , experience less physiological stress as compared to those who underwent open surgery.2,4 Whether the laparoscopic cholecystectomy be beneficial in patients having cardiac dysfunction as the advantage will be less physiological stress and disadvantage of pneumoperitoneum is a matter of concern for surgeon as well as anesthetists. Also a thorough knowledge into the effect of pneumoperitoneum and reverse Trendelenburg positioning on the cardiac physiology especially with respect to patients with a diseased myocardium.5 In present study, hemodynamic parameters and cardiac function in patients undergoing laparoscopic cholecystectomy in patients with moderate to severe left ventricular dysfunction was studied.

              

MATERIAL AND METHODS

Present study was prospective, comparative study, conducted in Department of Anaesthesia & Intensive Care, PGIMER, Chandigarh, India. Study duration was of 1 year (April, 2019 to March, 2020). Institutional ethical committee approval was obtained prior to start of study.

Inclusion criteria: Patients 18-65 years age, with echocardiographic findings consistent with presence of moderate to severe left ventricular systolic dysfunction, planned for laparoscopic cholecystectomy, Consented for participation

Exclusion criteria: BMI > 35 kg/m2. Coexisting stenotic valve lesions or right ventricular dysfunction. Presence of electrocardiographic findings of arrhythmia. NYHA IV physical status. End stage hepatic/renal/pulmonary disease

Study was explained and a written informed consent was taken. Apart from the demographic variables, history of cardiac medications and prior history of admission to the ER or cardiac adverse events was also noted. The echocardiography was done by an experienced cardiologist and LV systolic dysfunction was graded as mild (LVEF 41–45%), moderate (LVEF 36–40%), or severe (LVEF (35%).6

Pre-operative 8 hour fasting was advised. followed. Patients were informed on the day prior to the surgery about the study and a written informed consent was taken. In operation theatre, cardiac output, Invasive blood pressure monitoring and Systemic vascular resistance (both from 2D echo, FloTrac system), non-invasive blood pressure monitoring, heart rate, stroke volume variation, central venous pressure (right internal jugular vein canula connected to the pressure transducing system), systolic pressure variation, pulse pressure variation were noted at the predefined study time points.

All study parameters were recorded at the following time points.

  • T1 - Pre-induction
  • T2 - 10 minute after induction
  • T3 - when pneumoperitoneum with intra-abdominal (IAP) pressure of 12mm Hg is achieved,
  • T4 - 10 minute after reverse Trendelenburg position,
  • T5 - 10 minute after deflation of pneumoperitoneum.

Under general anaesthesia, after creation of pneumoperitoneum, once IAP of 12mm Hg was achieved, 2D echocardiography was done (T2). Intraoperatively IAP was maintained to < 12 mmHg. Following this reverse Trendelenburg positioning was done. 10 min after the positioning the 2nd sample of ABG was taken. After 10 min after exsufflation (T5), third ABG sample was taken.

The surgery was done according to the standard protocol. If any complication was refractory to medical management or surgical conversion to open procedure was deemed necessary, the patient was excluded from the study. The adverse complications anticipated during creation of pneumoperitoneum and surgery were hemodynamic changes like hypotension, hypertension, and rhythm abnormalities

The patient was shifted to PACU after fulfilling the criteria that patient was able to respond to verbal stimuli and ensuring that pain was adequately managed. All cardiac patients were followed till hospital discharge and any in hospital morbidity were noted. Data was collected and compiled using Microsoft Excel, analysed using SPSS 23.0 version. Group comparisons of values of data were made with Mann-Whitney test for 2 groups. For Normally distributed data Student t-test was applied to compare 2 groups. A P value < 0.05 was considered statistically significant

 

RESULTS

15 patients with moderate to severe LV dysfunction undergoing laparoscopic cholecystectomy were enrolled in the study. In present study, mean age was 55.57 ± 7.52 years. Gender wise male (26.67 %) were less than female (73.3 %) patients. Medical comorbidities were Hypertension (80 %), Diabetes mellites 3 (20 %) and Previous history of cardiac intervention (20 %). 73.3 % patients had moderate Left ventricular dysfunction (LVEF 36–40%) while 26.67 % had severe Left ventricular dysfunction (LVEF < 36%).


 

 

Table 1: Demographic characteristics of both groups

Parameter

No. of cases (%)/ Mean ± SD

Age in years

55.57 ± 7.52

Gender

 

Male

4 (26.67 %)

Female

11 (73.3 %)

Weight in kg

64.43±14.62

Height in cm

164.29±11.15

BMI in kg/m2

23.66±2.77

BSA in m2

1.7±0.25

Medical comorbidities

 

Hypertension

12 (80 %)

Diabetes mellites

3 (20 %)

Previous history of cardiac intervention

3 (20 %)

Left ventricular dysfunction

 

Moderate (LVEF 36–40%)

11 (73.3 %)

Severe (LVEF < 36%)

4 (26.67 %)

The mean HR values, decrease in mean HR was 6.5% On intragroup statistical analysis, no significant change in mean HR is seen at T2, T3, T4 or T5 from T1 was noted.

 

Table 2: Heart rate at the defined time points of the study.

Heart rate (beats/min)

Mean ± SD

P value from T1

HR at T1

81±10.82

-

HR at T2

75.71±12.84

.411

HR at T3

74.29±14.16

.338

HR at T4

75.43±15.21

.464

HR at T5

71.86±13.31

.106

From T1 to T2, the fall in mean MAP was 9.7% while from T2 to T3, 32.5% increase in MAP was seen. On intragroup statistical analysis, no significant change in mean MAP was noted.

 

Table 3: Mean arterial pressure at defined time points of the study

Mean arterial pressure (mm Hg)

Mean ± SD

P value from T1

MAP at T1

92±12.81

-

MAP at T2

83±13.18

.316

MAP at T3

102.43±16.46

.083

MAP at T4

97.57±13.15

.368

MAP at T5

97.29±13.95

.472

From T1 to T2, the increase in mean CVP was 29.3% and mean CVP values decrease from T4 to T5 and reach values approximately similar to the T1 levels. On intragroup statistical analysis, significant increase in mean CVP was seen at T3, T4 from T1.

Table 4: Mean CVP at the defined time points of the study.

Central venous pressure (mm Hg)

Mean ± SD

P value from T1

CVP at T1

7.86±2.41

-

CVP at T2

10.14±4.71

.121

CVP at T3

12.86±3.24

.006

CVP at T4

12.57±3.26

.008

CVP at T5

8.57±3.21

.593

From T1 to T2, no change in mean SVR was seen, while from T2 to T3 and T4, there was an increase in the mean SVR, mean SVR values at T5 return to the approximately the T1 levels after CO2 exsufflation.

 

Table 5: Mean SVR at the defined time points of the study.

Systemic vascular resistance (Dynes.sec.cm-5)

Mean ± SD

P value from T1

SVR at T1

1503.71±674.3

-

SVR at T2

1505±463.33

.995

SVR at T3

1988.86±755.96

.041

SVR at T4

1970.57±629.86

.058

SVR at T5

1702.86±849.44

.387

From T1 to T2, the fall in mean CO was 15.9% while at T3 9.7% (from T2) fall in CO was noticed and the CO does return to similar pre-induction T1 values at T5.

Table 6: Mean cardiac output at the defined time points of the study.

Cardiac output (L/min)

Mean ± SD

P value from T1

CO at T1

4.98±1.46

-

CO at T2

4.19±1.33

.180

CO at T3

3.78±1.12

.092

CO at T4

3.71±1.13

.067

CO at T5

4.66±1.3

.507

The mean EtCO2 values were statistically significant when compared from P1 values.

 

Table 7: Mean EtCO2 in the two groups at the defined time points of the study.

EtCO2 (mm Hg)

Mean ± SD

P value from T1

EtCO2 at T1

29.86±2.34

-

EtCO2 at T2

35.43±5.32

.011

EtCO2 at T3

34.71±5.94

.045

EtCO2 at T4

37.29±4.57

.006

EtCO2 at T5

37.57±5.86

.012

The PaCO2 values were comparable between predefined time points in the study.

 

TABLE 8: Mean PaCO2 in the two groups at the defined time points of the study.

PaCO2 (mm Hg)

Mean ± SD

P value from T1

PaCO2 at T1

36.19±6.75

-

PaCO2 at T4

39.86±4.95

.249

PaCO2 at T5

39.69±6.71

.354

Out of the 15 patients in the study group, 4 patients had episodes of hypotension, 1 patient in had an episode of bradycardia requiring intervention. No significant complications occurred during immediate postoperative period as well as during the hospital stay. On 3 month follow up of these patient (telephonically), no mortality or morbidity has been recorded.

 


DISCUSSION

Laparoscopic cholecystectomy is a widely accepted surgical procedure for treatment of gall bladder stones. The superior cosmesis ,early return to daily activities, appeal of diminished pain and fatigue are responsible for its popularity in surgery field.2 Laparoscopic cholecystectomy minimizes abdominal incision and therefore pulmonary function and diaphragmatic function remain preserved. Laparoscopic cholecystectomy decreases the incidence of postoperative ileus, helps early ambulation, has economic benefits, helps early ambulation with shorter hospital stay , early return to work and normal daily activities. According to the demographic data, the patients belong to a significantly older age group (55± 7 years), which can be very well explained by the fact that incidence of LV systolic dysfunction and hypertension increases significantly with age.7 Patients in the study per se are predominantly females (72%). A population based study done in the north Indian population confirms a greater prevalence of cholecystitis in females as compared to males.8 Hein et al.,9 in his study, included patients with severe cardiac dysfunction for evaluated the hemodynamic changes in laparoscopic cholecystectomy .They studied in 17 patients with ASA physical status III and IV undergoing elective laparoscopic cholecystectomy. They used standardized general anesthetic and surgical technique for all patient. In addition to routine monitoring they used pulmonary artery cannulation and radial. They noticed that significantly decreased in CI (p < 0.05) following insufflation and remained low until exsufflation. After CO2 insufflation MAP, SVR, and PA occlusion pressure increased significantly (p < 0.05) Required administration of nitroglycerin to maintain the MAP and SVR in three out of 17 patients.9 Dhoste et al.,10 did study in elderly ASAIII patients for monitoring hemodynamic changes in laparoscopic cholecystectomy. They included 16 patients of aged > 75 years. The author had used radial and pulmonary artery cannulation in addition to routine ASA monitoring techniques. After anesthetic induction they noted that patients had cardiovascular depression and post peritoneal insufflation, they noted an improvement of cardiovascular function with increases in cardiac index (+19%), heart rate (+21%), MAP (+19%). They hypothesized this effect to be as a result of a sympathetic stimulation during creation of pneumoperitoneum.14 The other cardiac output measurement technique which is lesser invasive to the standard techniques (eg.thermodilution method through pulmonary artery catheters) is pulse contour analysis of arterial waveform. Flo Trac is one such moniter which uses the above principle to obtain continuous cardiac output measurements. Its calculations are based on arterial waveform characteristics after adjustment for vascular compliance. It does not require frequent calibration unlike the PiCCO techniques.11,12 Strength of present study was use of less invasive technique for monitoring of cardiac parameters. Limitations of present study were small sample size and Flow track was not available for all patients due to resources limitation. Also observations were taken at defined time points; however continuous monitoring of the cardiac parameters can be of more help to observe the trend.

 

CONCLUSION

Optimization of cardiac status, administered of balanced anaesthesia and 10-12 mmHg pressure pneumoperitoneum are essential steps for patients’ safety. laparoscopic cholecystectomy may be safely done in cardiac patients with moderate to severe left ventricular systolic dysfunction patients under the supervision of an experienced consultant anaesthesiologist..

 

REFERENCES

  • Silverstein A, Costas A, Gakwaya MR, Lule J, Meara JG, Shrime MG, et al. Laparoscopic versus open cholecystectomy: A Cost-Effectiveness Analysis at Rwanda Military Hospital. world J Surgery. 2017;41:1225–33.
  • Rubert CP, Farias FV, Higa RA. Comparison between open and laparoscopic elective cholecystectomy in elderly, in a teaching hospital. Rev Col Bras Cir 2016;43:2–5.
  • Radunovic M, Lazovic R, Popovic N, Magdelinic M, Bulajic M, Radunovic L, et al. Complications of laparoscopic cholecystectomy: Our experience from a retrospective analysis. Maced J Med Sci. 2016; 4:641-646.
  • Atkinson TM, Giraud GD, Togioka BM, Jones DB, Cigarroa JE. Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation. 2017;135:700-710
  • Umar A, Mehta KS, Mehta N. Evaluation of hemodynamic changes using different intra-abdominal pressures for laparoscopic cholecystectomy. Indian J Surg. 2013; 75:284-289
  • Narayan K, Oommen R, Thomson V.S, Jose JV Assessment of left ventricular systolic function by velocity vector imaging. Indian Heart J. 2012;64:146–9.
  • Kelman GR, Swapp GH, Smith I, et al. Cardiac output and arterial blood-gas tension during laparoscopy. Br J Anaesth.1972;44:1155-62
  • Rasmussen JP, Dauchot PJ, Depalma RG, Sorensen B, Regula G, Anton AH, et al. Cardiac function and hypercarbia. Arch Surg. 1978; 113;1196-1200.
  • Hein HAT, Joshi GP, Ramsay MAE, Fox LG, Gawey BJ, Hellman CL, et al. Hemodynamic changes during laparoscopic cholecystectomy in patients with severe cardiac disease. J Clin Anesth. 1997;9:261-265.
  • Dhoste K, Lacoste L, Karayan J, Lehuede MS, Thomas D, Fusciardi J. Haemodynamic and ventilatory changes during laparoscopic cholecystectomy in elderly ASA III patients. Can J Anaesth. 1996; 43:783-788.
  • Manecke GR. Edwards. FloTracTM sensor and VigileoTM monitor: Easy, accurate, reliable cardiac output assessment using the arterial pulse wave. Expert Rev Med Devices.2005; 2:523-7
  • Biancofiore G, Critchley LA, Lee A, Yang XX, Bindi LM, Esposito M, et al. Evaluation of a new software version of the FloTrac/Vigileo (Version 3.02) and a comparison with previous data in cirrhotic patients undergoing liver transplant surgery. Anesth Analg 2011; 113: 515–22.


























 








 




 








 

 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.